Cargando…
HER2-driven breast cancer suppression by the JNK signaling pathway
The HER2(+) subtype of human breast cancer is associated with the malignant transformation of luminal ductal cells of the mammary epithelium. The sequence analysis of tumor DNA identifies loss of function mutations and deletions of the MAP2K4 and MAP2K7 genes that encode direct activators of the JUN...
Autores principales: | Itah, Zeynep, Chaudhry, Shanzah, Raju Ponny, Sithara, Aydemir, Ozkan, Lee, Alexandra, Cavanagh-Kyros, Julie, Tournier, Cathy, Muller, William J., Davis, Roger J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942916/ https://www.ncbi.nlm.nih.gov/pubmed/36656864 http://dx.doi.org/10.1073/pnas.2218373120 |
Ejemplares similares
-
Phosphorylation of RXRα mediates the effect of JNK to suppress hepatic FGF21 expression and promote metabolic syndrome
por: Vernia, Santiago, et al.
Publicado: (2022) -
Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathway
por: Vernia, Santiago, et al.
Publicado: (2013) -
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
por: Manieri, Elisa, et al.
Publicado: (2020) -
Generation and validation of a conditional knockout mouse model for desmosterolosis
por: Kanuri, Babunageswararao, et al.
Publicado: (2021) -
Oppositional poly(A) tail length regulation by FMRP and CPEB1
por: Shin, Jihae, et al.
Publicado: (2022)